MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AG-1478 hydrochloride

CAS No. : 170449-18-0

MCE 站：AG-1478 hydrochloride

产品活性：AG-1478 hydrochloride (Tyrphostin AG-1478 hydrochloride) 是一种选择性的 EGFR 酪氨酸激酶抑制剂，IC₅₀ 为 3 nM。AG-1478 hydrochloride 对 HCV 和脑心肌炎病毒 (EMCV) 具有抗病毒作用。

研究领域：JAK/STAT Signaling  |  Protein Tyrosine Kinase/RTK  |  Anti-infection

作用靶点：EGFR  |  HCV  |  Influenza Virus

In Vitro: AG-1478 (AG1478) is irreversible for growth regulation of human lung (A549) and prostate (DU145) cancer cell lines, cultured in chemically defined DMEM/F12 medium. AG-1478 seems to be more effective at lower concentrations, but is unable to completely inhibit growth of A549 cells. Inhibition of EGFR by specific tyrosine kinase inhibitor AG-1478 (AG1478) significantly decreases the angiotensin II-mediated synthesis of TGF-β and fibronectin by cardiac fibroblasts. EGFR is pharmacologically inhibited by small-molecule inhibitor AG-1478 with IC₅₀ of 4 nM. Both Polyfect (PF) and Superfect (SF) treatment lead to increased apoptosis in HEK 293 cells to a similar extent as assessed by flow cytometry. The antioxidant, tempol, significantly reduced dendrimer-mediated apoptosis for both PF and SF. AG-1478 (AG1478), at a 10-fold higher dose (100 μM) than used in signaling studies, is used as a positive control and significantly induced apoptosis in HEK 293 cells.

In Vivo: Administration of AG-1478 (AG1478) significantly reduces myocardial inflammation, fibrosis, apoptosis, and dysfunction in both two obese mouse models. ApoE^-/- mice are first fed with HFD for 8 weeks (ApoE-HFD), and then administrated with AG-1478 (10 mg/kg/day) or 542 (10 mg/kg/day) for another 8 weeks by oral gavage. AG-1478 or 542 treatment blocks HFD induced cardiac EGFR phosphorylation in vivo, without affecting the plasma level of low density lipoprotein (LDL) and total triglyceride (TG). Administration of EGF (10 nM) leads to a robust and reproducible elevation in EGFR phosphorylation that can be blocked by AG-1478 (AG1478), a known inhibitor of EGFR phosphorylation. Increasing doses of Polyfect (PF) result in a significant reduction in EGF-induced EGFR phosphorylation (p<0.05) but this is to a lesser extent than observed with AG1478.

相关产品：Acetylcysteine  |  U0126-EtOH  |  Gefitinib  |  Trastuzumab  |  Erlotinib  |  Resiquimod  |  Tunicamycin  |  Cetuximab  |  Vadimezan  |  AG490  |  Favipiravir  |  Curcumin  |  Camptothecin  |  Aprotinin  |  Oseltamivir acid  |  Honokiol  |  Geldanamycin  |  Ribavirin  |  Genistein  |  Emricasan  |  Rifampicin  |  Deferiprone  |  Baicalein  |  Mycophenolic acid  |  U18666A  |  AG-1478  |  EIDD-1931  |  AEBSF hydrochloride  |  α-Vitamin E

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。